PMCPA Case Analysis

Over 2,000 real rulings β€” analysed for what they mean to your team. Published every day.

All Cases PMCPA Case of the Week PMCPA Cases

Showing 1914 cases

2013
CASE
AUTH/2587/3/13 Almirall

AUTH/2587/3/13: Anonymous gastroenterology consultant v Almirall (Constella) – no breach over alleged free stock inducement

Complaint alleged an Almirall representative offered free Constella stock as a β€œtrial” to support a formulary application. Panel found the complainant provided…

2013
CASE
AUTH/2641/9/13 Lundbeck

AUTH/2641/9/13: Chief Pharmacist v Lundbeck β€” Cipralex promotional email (no breach)

A chief pharmacist complained about a Lundbeck promotional email for Cipralex sent via a database agency to local prescribers. The Panel found…

2013
CASE
AUTH/2611/6/13 Janssen ⭐ Case of the Week

AUTH/2611/6/13: Anonymous renal nurse v Janssen (Durogesic branded pens in conference delegate bags) – No breach on appeal

A renal nurse complained that Durogesic DTrans branded pens were in BRS 2013 delegate bags. Panel found a breach of Clause 18.3,…

2013
CASE
AUTH/2629/8/13 Menarini

Anonymous v Menarini: Sponsorship of BJMA β€˜scientific meeting’ found mainly social (AUTH/2629/8/13)

Menarini sponsored speakers and an exhibition stand at a BJMA UK meeting. The Panel found the event’s main purpose was social/cultural with…

2013
CASE
AUTH/2645/10/13 Amgen

AUTH/2645/10/13 & AUTH/2647/10/13: Patient v Amgen and GlaxoSmithKline (Prolia) – No breach

A patient complained about Prolia patient information, a German leaflet being supplied, and alleged missing side-effect information and β€œyellow marker/black triangle” issues.…

2015
CASE
Bausch

Bausch & Lomb breached ABPI Code over Pulse β€œQuick Guide” on anaphylaxis: disguised promotion and misleading dose/needle depth claims

A Pulse β€œQuick Guide” funded by Bausch & Lomb was found to resemble independent editorial content and included misleading claims about skin-to-muscle…

2015
CASE
AUTH/2747/1/15 Astellas Pharma Europe

Astellas Pharma Europe: Milan β€˜advisory board’ ruled promotional and not a genuine advisory board (Xtandi/enzalutamide) (AUTH/2747/1/15)

Large Milan meeting billed as an advisory board was ruled not genuine; UK HCPs were paid to attend what was deemed promotional…

2015
CASE
AUTH/2758/5/15 Stirling Anglian ⭐ Case of the Week

AUTH/2758/5/15: Galen v Stirling Anglian β€” CosmoCol abbreviated ad and leavepiece breaches (pack/cost info and missing active ingredients)

MIMS β€œabbreviated” CosmoCol ad included pack size/cost and other claims, so needed prescribing info. Both the ad and a leavepiece failed to…

2014
CASE
AUTH/2741/12/14 Chiesi

Chiesi SOP training criticised as a β€˜tick-box’ validation exercise ahead of PMCPA audit (AUTH/2741/12/14)

A representative alleged rushed SOP training and answer-changing to secure 100% scores before a PMCPA audit. Panel found validation across six SOPs…

2014
CASE
AUTH/2732/9/14 Janssen

Janssen: β€˜Invokana available to prescribe’ letter misled some GPs about local prescribing restrictions (AUTH/2732/9/14)

Janssen admitted a β€˜Dear Doctor’ letter said Invokana was available for GPs to prescribe in certain CCGs, but in 39 CCGs only…

2014
CASE
AUTH/2717/5/14 Roche Products

AUTH/2717/5/14: Roche voluntary admission after MabThera journal advertising appeared on four pages (Clause 6.3)

Roche admitted a British Journal of Haematology issue carried four pages of MabThera advertising due to a printer error (a bound-in card…

2013
CASE
AUTH/2667/11/13 Amgen

Amgen: delayed clinical trial results disclosure for Nplate (romiplostim) – breach of Clauses 21.3 and 9.1 (AUTH/2667/11/13)

A public complaint about trial transparency found one Nplate trial with UK involvement was disclosed late on ClinicalTrials.gov, breaching Clauses 21.3 and…

2008
CASE
AUTH/2087/1/08 Flynn Pharma ⭐ Case of the Week

AUTH/2087/1/08: UCB v Flynn Pharma β€” β€œDear Doctor” letter during Equasym shortage and β€˜only direct replacement’ claim for Medikinet XL

Flynn sent a β€œDear Doctor” letter during an Equasym supply shortage, promoting Medikinet/Medikinet XL. Panel found no issue with referencing the shortage,…

2015
CASE
Daiichi-Sankyo UK

Daiichi-Sankyo photo booth at ESC Congress: emailed delegate photos ruled a prohibited gift (Clause 18.1)

At ESC 2015, Daiichi-Sankyo emailed delegates photos taken in a stand photo booth. PMCPA ruled the emailed photos were a gift supplied…

2016
CASE
AUTH/2855/7/16 Boehringer Ingelheim

Boehringer Ingelheim and Lilly: Abasaglar email wrongly claimed formulary approval in NHS Sunderland CCG (AUTH/2855/7/16, AUTH/2856/7/16)

A promotional email said Abasaglar was approved on the NHS Sunderland CCG formulary. The Panel found this misleading because no such formulary…

Ask questions about any PMCPA case

Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β€” ask about precedents, clauses, and how they apply to your situation.

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training